EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Metabolism of cerebroside sulfate and subcellular distribution of its metabolites in cultured skin fibroblasts derived form controls metachromatic leukodystrophy globoid cell leukodystrophy and farber disease



Metabolism of cerebroside sulfate and subcellular distribution of its metabolites in cultured skin fibroblasts derived form controls metachromatic leukodystrophy globoid cell leukodystrophy and farber disease



Journal of Inherited Metabolic Disease 10(3): 293-296



The sphingolipidoses are generally understood to be lysosomal lipid storage diseases due to genetic enzymic defects of sphingolipid metabolism. However, the molecular mechanisms that lead to the clincal and pahtological manifestations remain largely obscure. Recent morphological and biochemical studies in neuronal storage diseases (Purpura and Suzuki, 1976) and animal models of gangliosidoses (Wood et al., 1985) suggested that altered membrane structure could be one of the causes of neuronal dysfunction. To understand the mechanism causing neurological dysfunctions in sphingolipidoses, clarification of the synthesis, translocation and insertion of sphingolipids in the different subcellular components in normal and pathological states is essential. This paper reports the metabolism of cerebroside sulphate (CS) and the subcellular distribution of its metabolite in cultured skin fibroblasts from normal control, metachromatic leukodystrophy (MLD; McKusick 25010), globoid cell leukodystrophy (GLD; McKusick 24520) and Farber disease (McKusick 22800).

(PDF emailed within 1 workday: $29.90)

Accession: 005883643

Download citation: RISBibTeXText

PMID: 3123795



Related references

Metabolism of cerebroside sulfate and subcellular distribution of its metabolites in cultured skin fibroblasts from controls, metachromatic leukodystrophy, and globoid cell leukodystrophy. Journal of Clinical Investigation 81(2): 310-317, 1988

Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblasts. Journal of Clinical Investigation 70(1): 89-97, 1982

Correction of abnormal cerebroside sulfate metabolism in cultured metachromatic leukodystrophy fibroblasts. Science 172(3989): 1263-1265, 1971

Metabolism of fatty acid-labeled cerebroside sulfate in cultured cells from controls and metachromatic leukodystrophy patients. Use in the prenatal identification of a false positive fetus. Journal of Laboratory and Clinical Medicine 98(5): 704-714, 1981

Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease). Neuropediatrics 15 Suppl: 32-36, 1984

Cerebroside sulfate hydrolysis by fibroblasts from a parent with metachromatic leukodystrophy. Journal of Pediatrics 92(5): 782-784, 1978

Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Current Opinion in Hematology 6(6): 377-382, 1999

The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. Journal of Inherited Metabolic Disease 18(4): 398-412, 1995

Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Current Opinion in Neurology 12(2): 167-176, 1999

Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy. Current Opinion in Molecular Therapeutics 10(5): 471-478, 2008

Impaired cerebroside sulfate hydrolysis in fibroblasts of sibs with "pseudo" arylsulfatase A deficiency without metachromatic leukodystrophy. Pediatric Research 17(9): 701-704, 1983

Globoid cell (Krabbe's) leukodystrophy: heterozygote detection in cultured skin fibroblasts. American Journal of Human Genetics 25(6): 604-609, 1973

Multiple sulfatase deficiencies in cultured skin fibroblasts. Occurrence in patients with a variant form of metachromatic leukodystrophy. Archives of Neurology 30(2): 153-156, 1974

Galactosylceramide and galactosylsphingosine loading studies in cultured skin fibroblasts in human and murine globoid cell leukodystrophy. Biochemical & Biophysical Research Communications 166(2): 1053-1060, 1990

Globoid cell leukodystrophy (Krabbe's disease). Metabolic studies with cultured fibroblasts. Journal of the Neurological Sciences 38(3): 409-419, 1978